Repository logoGCRIS
  • English
  • Türkçe
  • Русский
Log In
New user? Click here to register. Have you forgotten your password?
Home
Communities
Browse GCRIS
Overview
GCRIS Guide
  1. Home
  2. Browse by Author

Browsing by Author "Yavuz, Berrin Benli"

Filter results by typing the first few letters
Now showing 1 - 1 of 1
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Article
    Investigation of the Impact of Vaginal Marker Utilization on Radiotherapy Treatment Plans Created with Various Planning Systems in Endometrial Cancer Patients
    (Wolters Kluwer Medknow Publications, 2025) Demir, Hikmettin; Yavuz, Berrin Benli; Sahin, Ahmet
    Purpose:Our aim is to compare treatment plans with vaginal markers used in radiotherapy target volume definition with those without markers, which we have not encountered in our literature searches, and to investigate whether patients with endometrial cancer (EC) can undergo treatment with a single simulation tomography.Materials and Methods:A total of twenty patients with EC were randomly selected. All patients underwent a computerized tomography in the supine position. During the scan, the arms were folded over the chest, and the feet were fixed with a foot immobilizer. Tomography scans were performed with a vaginal marker. A total of four treatment plans were made by a medical physicist using tomography images with both vaginal markers (CT Set 1) and 0 Hounsfield units assigned to the vaginal marker (CT Set 2) under the same conditions.Results:The mean doses of maximum and mean of planning target volume (PTV) and critical organs were derived from the data obtained from the treatment plans created using CT Set 1 and CT Set 2. No significant differences were observed regarding PTV or critical organs when comparing the plans of CT Set 1 and CT Set 2 in both Treatment Planning Systems.Conclusions:Dosimetric comparison of plans with and without vaginal markers, no difference was found in terms of dosimetric parameters. Therefore, we suggested that a clinical decision can be made to plan with vaginal markers, thus ensuring that the patient does not receive an unnecessary second tomography dose.
Repository logo
Collections
  • Scopus Collection
  • WoS Collection
  • TrDizin Collection
  • PubMed Collection
About
  • Contact
  • GCRIS
  • Research Ecosystems
  • Feedback
  • OAI-PMH

Powered by Research Ecosystems

  • Privacy policy
  • End User Agreement
  • Feedback